Skip to Main Content

What’s it like to watch gene therapy happen? Is the next big cancer clinical trial going to work? And is “right to try” going to defang the FDA?

We tackle all that and more on the latest episode of “The Readout LOUD,” STAT’s biotech podcast. There’s a discussion of unicorns, a deep dive into Incyte’s immunotherapy, and multiple references to monkey urine. Plus STAT’s Eric Boodman joins us once more to go behind the scenes on a landmark medical procedure.

For more on the topics we cover, here’s the right-to-try news; here’s a story on Hong Kong’s interest in biotech; and here’s Eric’s story on Spark Therapeutics.


We’ll be back next Thursday evening — and every Thursday evening — so be sure to sign up on iTunes, Stitcher, Google Play, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].